PharmaSGP Holding SE (PSG) — Cash Flow-to-Debt Ratio
PharmaSGP Holding SE (PSG) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2025, meaning its operating cash flow of €4.22 Million could theoretically repay 0% of its total liabilities (€81.51 Million) in one year. Explore PSG long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PharmaSGP Holding SE Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for PharmaSGP Holding SE across 10 annual periods. Also explore how large is PharmaSGP Holding SE's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for PharmaSGP Holding SE (2014–2024)
Year-by-year debt coverage analysis for PharmaSGP Holding SE. For market capitalisation and broader financial context, see PharmaSGP Holding SE market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | €24.88 Million | €82.31 Million | ▲ +3.9% |
| 2023 | 0.29x | €26.64 Million | €91.55 Million | ▲ +15.4% |
| 2022 | 0.25x | €24.71 Million | €98.01 Million | ▲ +91.7% |
| 2021 | 0.13x | €12.24 Million | €93.06 Million | ▼ -88.6% |
| 2020 | 1.15x | €15.46 Million | €13.44 Million | ▼ -46.8% |
| 2019 | 2.16x | €17.63 Million | €8.16 Million | ▲ +234.8% |
| 2017 | 0.65x | €14.25 Million | €22.09 Million | ▲ +308.7% |
| 2016 | 0.16x | €3.55 Million | €22.47 Million | ▼ -65.0% |
| 2015 | 0.45x | €10.59 Million | €23.46 Million | ▲ +68.0% |
| 2014 | 0.27x | €5.41 Million | €20.13 Million | — |